A complete application in a minute
Tailored resume and cover letter, ready to send.
Trace Neuroscience, Inc. in Boston, MA, seeks a Clinical Scientist to shape clinical strategy for ALS and other neurodegenerative programs, guiding trials and regulatory submissions. The role requires leadership across Clinical Operations, Regulatory, Biostatistics, Translational Medicine, and Research.
The ideal candidate holds a Ph.D. or M.D. with 5+ years in biotech/pharma clinical development, including first-in-human and Phase 2 studies, and demonstrates rigorous scientific and clinical
At Trace Neuroscience (Trace), our vision is to bring the promise of genetic medicine to all people living with ALS. ALS, or amyotrophic lateral sclerosis, is a rapidly progressive, fatal, neuromuscular disease that affects motor neurons in the brain and spinal cord. It is a devastating disease for people living with ALS and their families. Trace is a biotechnology company advancing innovative genetic therapies designed to restore UNC13A, an essential synaptic protein, to improve outcomes for people living with ALS. The same mechanism is also relevant for people living with frontotemporal dementia and probably other neurodegenerative diseases. Founded through collaboration among leading scientists, industry experts, and investors, Trace is developing a new generation of treatments grounded in human genetics and a deep understanding of disease biology.
At Trace, our values of urgency, unity, and drive fuel everything we do. We embrace a sense of immediacy, understanding that every moment matters for those living with ALS, as well as their caregivers and families. As a lean team, we foster a culture that combines individual accountability with a shared responsibility for our ambitious mission. We believe effective collaboration is essential, so we encourage open communication, mutual support, and collective problem-solving. Building on our founders' fundamental discoveries, our growing team is driven to turn cutting-edge science into effective medicine.
We invite you to consider an opportunity with Trace Neuroscience to help achieve our goal of delivering meaningful treatments to people living with ALS.
Reporting to the Chief Medical Officer, the Clinical Scientist will serve as a key member of the Clinical Development organization and provide medical and scientific expertise across Trace's clinical development programs. This individual will help shape the clinical strategy for our lead and future pipeline programs, supporting the advancement of innovative therapies for ALS and other neurodegenerative diseases.
The Clinical Scientist will work cross-functionally with Clinical Operations, Regulatory Affairs, Biometrics, Translational Medicine, Research, Quality, and external partners to support the design, implementation, and oversight of clinical trials. The role will engage with key opinion leaders and patient advocacy organizations and help translate emerging scientific insights into development decisions.
The ideal candidate is a collaborative, hands-on physician and/or scientist leader with experience in biotechnology drug development. This individual will thrive in a fast-paced, entrepreneurial environment and bring scientific rigor, sound clinical judgment, operational excellence, and a passion for improving the lives of people living with devastating diseases.
Ability to travel globally approximately 20-30% for investigator meetings, clinical trial oversight, advisory boards, regulatory meetings, and scientific congresses.
In compliance with applicable pay transparency laws, the expected base salary range for this position is $250,000 to $275,000 annually. This range represents the Company's good-faith estimate of the salary range for this role at the date of hire and is subject to change.
Trace Neuroscience is committed to creating a diverse environment and is proud to be an equal opportunity employer. We are dedicated to building an inclusive workplace where all employees can contribute, grow, and succeed while advancing our mission to deliver transformative therapies for people living with ALS.